4.7 Article

Risk Factors in the Development of Esophageal Adenocarcinoma

期刊

AMERICAN JOURNAL OF GASTROENTEROLOGY
卷 108, 期 2, 页码 200-207

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1038/ajg.2012.387

关键词

-

向作者/读者索取更多资源

OBJECTIVES: It is assumed that esophageal adenocarcinoma is the end result of a stepwise disease process that transitions through gastroesophageal reflux disease (GERD) and Barrett's esophagus. The aim of this study was to examine at what stage known risk factors exert their influence toward the progression to cancer. METHODS: We enrolled 113 consecutive outpatients without GERD, 188 with GERD, 162 with Barrett's esophagus, and 100 with esophageal adenocarcinoma or high-grade dysplasia (HGD). All patients underwent a standard upper endoscopy and completed a standardized questionnaire about their social history, symptoms, dietary habits, and prescribed medications. We used adjusted logistic regression analysis to assess risk factors between each two consecutive disease stages from the absence of reflux disease to esophageal adenocarcinoma. RESULTS: Overall, male gender, smoking, increased body mass index (BMI), low fruit and vegetable intake, duration of reflux symptoms, and presence of a hiatal hernia were risk factors for cancer/HGD. However, different combinations of risk factors were associated with different disease stages. Hiatal hernia was the only risk factor to be strongly associated with the development of GERD. For GERD patients, male gender, age, an increased BMI, duration of reflux symptoms, and presence of a hiatal hernia were all associated with the development of Barrett's esophagus. Finally, the development of cancer/HGD among patients with Barrett's esophagus was associated with male gender, smoking, decreased fruit and vegetable intake, and a long segment of Barrett's esophagus, but not with age, BMI, or a hiatal hernia. CONCLUSIONS: While some risk factors act predominantly on the initial development of reflux disease, others appear to be primarily responsible for the development of more advanced disease stages.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Gastroenterology & Hepatology

Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management

Ferdinando D'Amico, Daniel C. Baumgart, Silvio Danese, Laurent Peyrin-Biroulet

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Darvadstrocel for the treatment of perianal fistulas in Crohn's disease

Zhao Wu Meng, Daniel C. Baumgart

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Biochemistry & Molecular Biology

Leptin Downregulates Angulin-1 in Active Crohn's Disease via STAT3

Jia-Chen E. Hu, Christian Bojarski, Federica Branchi, Michael Fromm, Susanne M. Krug

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Gastroenterology & Hepatology

Expression of tricellular tight junction proteins and the paracellular macromolecule barrier are recovered in remission of ulcerative colitis

Jia-Chen E. Hu, Franziska Weiss, Christian Bojarski, Federica Branchi, Joerg-Dieter Schulzke, Michael Fromm, Susanne M. Krug

Summary: In remission of UC, tricellulin expression level and intestinal barrier functions were restored to normal after being impaired in active UC. This indicates a re-sealing of the impaired tricellular paracellular pathway and reduced uptake of antigens back to normal rates in remission of UC.

BMC GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome

Christian Bojarski, Paul Tangermann, Christian Barmeyer, Juliane Buchkremer, Ralf Kiesslich, Mark Ellrichmann, Stefan Schreiber, Carsten Schmidt, Andreas Stallmach, Robert Roehle, Christoph Loddenkemper, Severin Daum, Britta Siegmund, Michael Schumann, Reiner Ullrich

Summary: The study evaluated the diagnostic accuracy of confocal laser endomicroscopy for identifying wheat sensitivity in patients with IBS, showing low sensitivity and specificity.
Article Immunology

Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8(+) T cells

Malte Lehmann, Kristina Allers, Claudia Heldt, Jenny Meinhardt, Franziska Schmidt, Yasmina Rodriguez-Sillke, Desiree Kunkel, Michael Schumann, Chotima Boettcher, Christiane Stahl-Hennig, Sefer Elezkurtaj, Christian Bojarski, Helena Radbruch, Victor M. Corman, Thomas Schneider, Christoph Loddenkemper, Verena Moos, Carl Weidinger, Anja A. Kuehl, Britta Siegmund

Summary: Infection with the SARS-CoV-2 virus causes pathological changes in intestinal tissues, including activation of CD8(+) T cells and apoptosis of epithelial cells. These findings provide a possible explanation for gastrointestinal symptoms associated with COVID-19.

MUCOSAL IMMUNOLOGY (2021)

Article Surgery

PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study

Federica Branchi, Rolf Klingenberg-Noftz, Kristina Friedrich, Nataly Burgel, Severin Daum, Juliane Buchkremer, Elena Sonnenberg, Michael Schumann, Christoph Treese, Hanno Troger, Donata Lissner, Hans-Jorg Epple, Britta Siegmund, Andrea Stroux, Andreas Adler, Winfried Veltzke-Schlieker, Daniel Autenrieth, Silke Leonhardt, Andreas Fischer, Christian Jurgensen, Ulrich-Frank Pape, Bertram Wiedenmann, Oliver Moschler, Maximilian Schreiner, Mathias Z. Strowski, Volkmar Hempel, Yvonne Huber, Helmut Neumann, Christian Bojarski

Summary: PuraStat gel is an effective tool for treating gastrointestinal bleeding, safely applicable as both primary and secondary therapy, and can serve as a bridge to surgery for temporary haemostasis. It shows high efficacy with low rebleeding rates.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2022)

Review Medicine, General & Internal

Innovative Diagnostic Endoscopy in Inflammatory Bowel Diseases: From High-Definition to Molecular Endoscopy

Christian Bojarski, Maximilian Waldner, Timo Rath, Sebastian Schuermann, Markus F. F. Neurath, Raja Atreya, Britta Siegmund

Summary: High-definition endoscopy is crucial in the initial diagnosis of inflammatory bowel disease (IBD), helping to characterize inflammation and differentiate between ulcerative colitis and Crohn's disease. In addition to videoendoscopy, the use of dyes sprayed via a catheter can improve detection rates of intraepithelial neoplasia. Virtual chromoendoscopy techniques should not be the sole surveillance strategy in IBD, while the results of oral methylene blue formulation show promise in increasing acceptance rates of classic chromoendoscopy.

FRONTIERS IN MEDICINE (2021)

Article Gastroenterology & Hepatology

The combination of clinical parameters and immunophenotyping of intraepithelial lymphocytes allows to assess disease severity in refractory celiac disease

Federica Branchi, Jakob Johann Wiese, Claudia Heldt, Subhakankha Manna, Violaine Dony, Christoph Loddenkemper, Christian Bojarski, Britta Siegmund, Thomas Schneider, Severin Daum, Michael Hummel, Verena Moos, Michael Schumann

Summary: This study investigated the associations between clinical characteristics of refractory celiac disease patients and aberrant intraepithelial lymphocytes, and evaluated the accuracy of immunophenotyping for identifying high-risk refractory celiac disease. The results showed that flow cytometry analysis is a good predictor for high-risk refractory celiac disease, and adding the evaluation of malabsorption to the diagnostic assessment improves accuracy.

DIGESTIVE AND LIVER DISEASE (2022)

Meeting Abstract Gastroenterology & Hepatology

THE REAL-WORLD EFFECTIVENESS OF USTEKINUMAB IN THE TREATMENT OF CROHN'S DISEASE

Amanda M. Johnson, Maria Barsky, Waseem Ahmed, Samantha Zullow, Jonathan S. Galati, Vipul Jairath, Neeraj Narula, Farhad Peerani, Benjamin H. Click, Elliot Coburn, Thucnhi T. Dang, Stephanie Gold, Manasi Agrawal, Rajat Garg, Manik Aggarwal, Danah Mohammad, Brendan P. Halloran, Gursimran Kochhar, Hannah Todorowski, Nabeeha Mohy-Ud-Din, James L. Izanec, Amanda M. Teeple, Christopher Gasink, Erik Muser, Zhijie Ding, Arun Swaminath, Komal Lakhani, Daniel Hogan, Samit Datta, Ryan C. Ungaro, Siddharth Singh, Brigid Boland, Matthew Bohm, Monika Fischer, Sagi Sashi, Anita Afzali, Thomas Ullman, Garrett Lawlor, Daniel C. Baumgart, Shannon Chang, David Hudesman, Dana J. Lukin, Ellen J. Scherl, Jean Frederic Colombel, Bruce E. Sands, Corey A. Siegel, Miguel D. Regueiro, William J. Sandborn, David H. Bruining, Sunanda V. Kane, Edward V. Loftus, Parambir Dulai

GASTROENTEROLOGY (2021)

Meeting Abstract Gastroenterology & Hepatology

SHORTER DISEASE DURATION IN PATIENTS WITH CROHN'S DISEASE IS ASSOCIATED WITH HIGHER RATES OF REMISSION WITH USTEKINUMAB

Stephanie Gold, Manasi Agrawal, Vipul Jairath, Jonathan S. Galati, Elliot Coburn, Benjamin H. Click, Farhad Peerani, Neeraj Narula, Samantha Zullow, Waseem Ahmed, Maria Barsky, Amanda M. Johnson, Thucnhi T. Dang, Rajat Garg, Manik Aggarwal, Danah Mohammad, Brendan P. Halloran, Gursimran Kochhar, Hannah Todorowski, Nabeeha Mohy-Ud-Din, James L. Izanec, Amanda M. Teeple, Christopher Gasink, Erik Muser, Zhijie Ding, Arun Swaminath, Komal Lakhani, Daniel Hogan, Samit Datta, Siddharth Singh, Brigid Boland, Matthew Bohm, Monika Fischer, Sagi Sashi, David H. Bruining, Sunanda V. Kane, Edward V. Loftus, Anita Afzali, Thomas Ullman, Garrett Lawlor, Daniel C. Baumgart, Shannon Chang, David Hudesman, Dana J. Lukin, William J. Sandborn, Ellen J. Scherl, Corey A. Siegel, Miguel D. Regueiro, Jean Frederic Colombel, Bruce E. Sands, Parambir Dulai, Ryan C. Ungaro

GASTROENTEROLOGY (2021)

Meeting Abstract Gastroenterology & Hepatology

PREGNANCY OUTCOMES IN WOMEN EXPOSED TO USTEKINUMAB IN THE CROHN'S DISEASE AND ULCERATIVE COLITIS CLINICAL TRIALS

Bincy P. Abraham, Elyssa Ott, Christopher Busse, Conor J. Murphy, Lindsay Miller, Daniel C. Baumgart, Ellen J. Scherl, Christopher Gasink

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial

Bhairavi Balram, Harshad Joshi, Karen Wong, Karen I. Kroeker, Levinus A. Dieleman, Brendan P. Halloran, Daniel C. Baumgart, Farhad Peerani

Summary: This study found that continuing 5-ASA therapy in ulcerative colitis patients escalated to infliximab did not provide additional benefit in controlling inflammation, and was not associated with increased likelihood of achieving clinical and endoscopic remission.

DIGESTIVE DISEASES AND SCIENCES (2021)

Meeting Abstract Gastroenterology & Hepatology

Tofacitinib for the Treatment of Ulcerative Colitis: An Updated Analysis of Infection Rates in the Tofacitinib Ulcerative Colitis Clinical Program

Kevin L. Winthrop, Edward V. Loftus, Daniel C. Baumgart, Ailsa Hart, Othman R. Alharbi, Leonardo Salese, Nervin Lawendy, Rajiv Mundayat, Chinyu Su, Walter Reinisch

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Meeting Abstract Gastroenterology & Hepatology

Clostridium difficile Infection in Patients With Ulcerative Colitis Treated With Tofacitinib in the Ulcerative Colitis Program: An Update as of May 2019

Edward V. Loftus, Alessandro Armuzzi, Daniel C. Baumgart, Jeffrey R. Curtis, Jami A. Kinnucan, Nana Koram, Leonardo Salese, Chinyu Su, Kenneth Kwok, John C. Woolcott

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

暂无数据